Negative cell cycle control of human T cells by β-galactoside binding protein (βGBP): Induction of programmed cell death in leukaemic cells

Journal of Cellular Physiology

Volumn 178, Issue 1, 1999, Pages 102-108

  Novelli, Francesco ^a   Allione, Alessandra ^a   Wells, Valerie ^b   Forni, Guido ^a   Mallucci, Livio ^b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GALAPTIN;

APOPTOSIS; ARTICLE; CELL CYCLE; GROWTH REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; QUANTITATIVE DIAGNOSIS;

ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GALECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEMAGGLUTININS; HUMANS; JURKAT CELLS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 3743087171     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199901)178:1<102::AID-JCP13>3.0.CO;2-6     Document Type: Article

References (39)

1. Askew DS, Ashmun RA, Simmons BC, Cleveland JL 1991. Constitutive c-myc expression in an IL3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6:1915-1922.
2. Aurias A, Rimbaut C, Buffe D, Zucker JM, Mazabraud A. 1984. Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study of four fresh tumours. Cancer Genet Cytogenet 12:21-25.
3. Baldini A, Gress T, Patel K, Muresu R, Chiariotti L, Wilhamson P, Boyd Y, Casciano I, Wells V, Bruni CB, Mallucci L, Siniscalco M. 1993. Mapping on human and mouse chromosomes of the gene for the β-galactoside binding protein, an autocrine-negative growth factor. Genomics 15:216-218.
4. Bridge JA, Borek DA, Neff JR, Huntrakoon M. 1990. Chromosomal abnormalities in clear cell sarcoma. Implication for histogenesis. Am J Clin Pathol 93:26-31.
5. Chiariotti L, Wells V, Bruni CB, Mallucci L. 1991. Structure and expression of the negative growth factor mouse β-galactoside binding protein gene. Biochim Biophys Acta 1089:54-60.
6. De Gregori J, Leone G, Miron A, Jakoi L, Nevins JR. 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci U S A 94:7245-7250.
7. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH. 1992. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on crosslinking of APO-1 cell surface antigens. J Immunol 149:3166-3173.
8. Evan GI, Brown L, Whyte M, Harrington E. 1995. Apoptosis and the cell cycle. Curr Opin Cell Biol 7:825-834.
9. Fanidi A, Harrington EA, Evan GI. 1992. Cooperative interaction between c-myc and Bcl-2 proto-oncogenes. Nature 359:554-556.
10. Fisher DE. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539-542.
11. Hartwell L. 1992. Defect in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546.
12. Korsmeyer SJ. 1992. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879-886.
13. Krek W, Xu G, Livingston DM. 1995. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell 83:1149-1158.
14. Li JJ, Deshaies RJ. 1993. Exercising self-restraint: discouraging illicit acts of S and M in eukaryotes. Cell 74:223-226.
15. Lowe SW, Ruley HE, Jacks T, Housman DE. 1993. p53-dependent apoptosis modulates the cytoxicity of anticancer agents. Cell 74: 957-967.
16. Mallucci L, Wells V. 1998. Negative control of cell proliferation. Growth arrest versus apoptosis. Role of βGBP. J Theor Med 1:169-173.
17. Massagué J. 1996. TGFβ signalling: receptors, transducers and Mad proteins. Cell 85:947-950.
18. Murray AW. 1992. Creative blocks: cell cycle checkpoints and feedback controls. Nature 359:599-604.
19. Nagata S, Goldstein P. 1995. The Fas death factor. Science 267:1449-1456.
20. News TA, Zhan Z, Elledye SJ. 1995. DNA polymerase links the DNA replication machinery to the S phase checkpoint. Cell 80:29-35.
21. Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW: 1997. E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis. Mol Cell Biol 17:1049-1056.
22. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
23. Reed JC. 1994. Bcl-2 and the regulation of programmed cell death J Cell Biol 124:1-6.
24. Rey JA, Bello MJ, de Campos JM, Vaquero J, Kusak ME, Sarasa JL, Pestana A. 1993. Abnormalities of chromosome 22 in human brain tumours determined by combined cytogenetic and molecular genetic approaches. Cancer Genet Cytogenet 66:1-10.
25. 1 to S transition, but not activation of human B lymphocytes. Exp Cell Res 171:213-222.
26. Steller H. 1995. Mechanisms and genes of cellular suicide. Science 267:1445-1449.
27. Strasser A, Harris AW, Cory S. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67:889-899.
28. Strasser A, Harris AW, Jacks T, Cory S. 1994. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79:329-339.
29. Suda T, Nagata S. 1994. Purification and characterisation of the Fas-ligand that induces apoptosis. J Exp Med 179:873-879.
30. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T, Van Dyke T. 1994. p53-dependent apoptosis suppresses tumour growth and progression in vivo. Cell 78:703-711.
31. Thompson CB. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
32. Turc Carel C, Dal Cin P, Rao U, Karakousis C, Sandberg AA. 1988. Recurrent breakpoints at 9q31 and 22q12.2 in extraskeletal myxoid chondrosarcoma. Cancer Genet Cytogenet 30:145-150.
33. Vaux, DL Cory S, Adams JM. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalise pre-B cells. Nature 335:440-442.
34. Wang Y, Szekely L, Okan I, Klein G, Wiman KG. 1993. Wild-type p53-triggered apoptosis is inhibited by Bcl-2 in a v-myc induced T cell lymphoma line. Oncogene 8:3427-3431.
35. Wells V, Mallucci L. 1988. Cell cycle regulation (G1) by autocrine interferon and dissociation between autocrine interferon and 2′-5′ oligoadenylate synthetase expression J Interferon Res 8:793-802.
36. Wells V, Mallucci L. 1991. Identification of an autocrine negative growth factor: mouse β-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell 64:91-97.
37. Wells V, Mallucci L. 1992. Molecular expression of the negative growth factor murine β-galactoside binding protein (mGBP). Biochim Biophys Acta 1121:239-244.
38. Wyllie AH, Kerr JF, Currie AR. 1980. Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306.
39. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P, Oven M. 1993. p53-mediated cell death: relationship to cell cycle control. Mol Cell Biol 13:1415-1423.